1999
DOI: 10.1021/tx990028s
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of Benzo[a]pyrene to trans-7,8-Dihydroxy-7,8-dihydrobenzo[a]pyrene by Recombinant Human Cytochrome P450 1B1 and Purified Liver Epoxide Hydrolase

Abstract: Recombinant human enzymes expressed in membranes obtained from Escherichia coli transformed with cytochrome P450 (P450) and NADPH-P450 reductase cDNAs were used to identify the human P450 enzymes that are most active in catalyzing the oxidative transformation of benzo[a]pyrene in vitro. Activation of benzo[a]pyrene to genotoxic products that cause induction of umu gene expression in Salmonella typhimurium NM2009 by P450 1A1 and P450 1B1 enzymes was found to be enhanced by inclusion of purified epoxide hydrolas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
100
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 147 publications
(105 citation statements)
references
References 36 publications
5
100
0
Order By: Relevance
“…CYP1B1 appears to be more active than CYP1A1 in the conversion of a number of PAHs to genotoxic intermediates (269). In the presence of epoxide hydrolase, both CYP1A1 and CYP1B1 catalyze the conversion of the archetypal PAH, benzo[a]pyrene, to its 7,8-dihydrodiol, and both enzymes can in turn metabolically activate this benzo[a]pyrene metabolite to a mutagenic form (269,271,272). Covalent adducts, formed by the reaction of PAH diol epoxide metabolites with guanine in mutational hotspots of critical genes such as that of the p53 tumor suppressor (273,274), may initiate tumorigenesis if not efficiently repaired.…”
Section: Mixtures and Ahr-mediated Effectsmentioning
confidence: 99%
“…CYP1B1 appears to be more active than CYP1A1 in the conversion of a number of PAHs to genotoxic intermediates (269). In the presence of epoxide hydrolase, both CYP1A1 and CYP1B1 catalyze the conversion of the archetypal PAH, benzo[a]pyrene, to its 7,8-dihydrodiol, and both enzymes can in turn metabolically activate this benzo[a]pyrene metabolite to a mutagenic form (269,271,272). Covalent adducts, formed by the reaction of PAH diol epoxide metabolites with guanine in mutational hotspots of critical genes such as that of the p53 tumor suppressor (273,274), may initiate tumorigenesis if not efficiently repaired.…”
Section: Mixtures and Ahr-mediated Effectsmentioning
confidence: 99%
“…In humans P450s most implicated in PAH activation are 1A1, 1B1 (39,40) and the AKRs most involved are (1A1, 1C1-1C4) (20,21,41). These enzymes are differentially expressed and regulated.…”
Section: Introductionmentioning
confidence: 99%
“…There are three major pathways for the activation of B[a]P. In the first pathway, P450 peroxidases catalyze the generation of radical cations (5), which lead to the formation of depurinating adducts and result in G to T transversions (6) (4,7,8) or to B[a]P-7,8-dione by aldo-keto reductases (AKR1A1 and AKR1C1 to -1C4) (9 -11) (Scheme 1).…”
mentioning
confidence: 99%